Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health Mar 20, 2024
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow Mar 19, 2024
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium Jan 25, 2024
